Christopher Behme
14Patents
5h-index
22Co-inventors
62Inventor score
Filing activity: Mar 26, 1999 → Jan 23, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7544699B2 | Aryl and heteroaryl compounds, compositions, and methods of use | Chemistry; Metallurgy | 20 | Expired |
| US6100434A | Method for synthesizing sevoflurane and an intermediate thereof | Chemistry; Metallurgy | 10 | Expired |
| US7906507B2 | Oxadiazoanthracene compounds for the treatment of diabetes | Chemistry; Metallurgy | 9 | Active |
| US7790714B2 | Oxadiazoanthracene compounds for the treatment of diabetes | Chemistry; Metallurgy | 7 | Active |
| US7727983B2 | Oxadiazoanthracene compounds for the treatment of diabetes | Chemistry; Metallurgy | 7 | Active |
| US8524708B2 | Oxadiazoanthracene compounds for the treatment of diabetes | Chemistry; Metallurgy | 4 | Active |
| US7122580B2 | Aryl and heteroaryl compounds and methods to modulate coagulation | Chemistry; Metallurgy | 4 | Expired |
| US8703766B2 | Oxadiazoanthracene compounds for the treatment of diabetes | Chemistry; Metallurgy | 4 | Active |
| US9120813B2 | Oxadiazoanthracene compounds for the treatment of diabetes | Chemistry; Metallurgy | 3 | Active |
| US8933222B2 | Oxadiazoanthracene compounds for the treatment of diabetes | Chemistry; Metallurgy | 2 | Active |
| US9175003B2 | Substituted azoanthracene derivatives and intermediates for preparation thereof | Chemistry; Metallurgy | 1 | Active |
| US8987295B2 | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US8383644B2 | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US6271422A | Method for fluoromethylation of alcohols via halogenative decarboxylation | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.